Covid-19 roundup: Takeda preps rollout of Novavax shot for next year — report; G20 targets 70% world vaccination rate by mid-2022
A couple days after Novavax filed for authorization of its Covid-19 vaccine in the UK, the company is reportedly plotting a Japanese rollout sometime next year.
Takeda, Novavax’s partner in Japan, is preparing to seek authorization for the vaccine in Japan in early 2022, the company’s CEO Christophe Weber told Reuters.
“We will need to assess whether the package that has been filed in the UK, for example, will satisfy the Japanese authorities,” he said, per Reuters, adding that he expects the shots will be ready by the beginning of the new year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
